Phase 4 Rheumatoid Arthritis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are willing and able to sign a consent form and take part in the study before anything begins.
• You are 18 years old or older.
• You can read and write in Dutch or French.
• You have been diagnosed with rheumatoid arthritis based on recognised medical classification standards.
• You have previously responded well to a medication called rituximab, meaning it worked for you at least once in the past.
• You are currently being treated with rituximab.
• Your doctor has determined that you need another round of rituximab treatment, based on Belgian reimbursement rules that measure how active your arthritis is.
• Your dose of methotrexate or a similar arthritis medication has been stable for at least 4 weeks before the study starts.

Who may not be able to join:

• You are currently taking a different type of biological arthritis medication (other than rituximab).
• You are currently taking a newer type of targeted arthritis medication (such as a JAK inhibitor) (confirm with trial site).
• You are pregnant or planning to become pregnant.
• You have a medical reason that means you cannot safely receive rituximab, based on the medication's guidelines and your doctor's judgement.

Important: Always verify eligibility with the trial site directly before applying.